Delivery Order SPE2DB24D2216-SPE2DB24FGMDK

Award Date 6/24/24
Potential Completion Date 6/25/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,105.05, is a delivery order contract for the supply of Testosterone 1% (25mg/2.5g) in packs of 2.5g. The contract has a completion date of February 6, 2025 and is a firm fixed-price agreement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,706.76, is a delivery order for the supply of Testosterone 1% (25mg/2.5g) in a 2.5g package. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,642.58, is for the delivery of testosterone 1% (50 mg/5 g) in packages of 5 grams. This is a firm fixed-price delivery order contract with a completion date of February 20, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of testosterone 1% (25mg/2.5g) in packs of unit doses, with a ceiling value of $2,003.02 and a performance period ending on October 31, 2023. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,339.30 firm-fixed-price contract is for the supply of testosterone 1% (50 mg/5 g) packs with a completion date of November 26, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of a specific pharmaceutical product, Testosterone 1% (25mg/2.5g) in a 2.5g package, with a firm fixed price of $2,825.41 and a completion date of May 23, 2025. The contract is not set aside and is awarded as a standalone delivery order, rather than through a larger contract vehicle....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,193.70, is for the delivery of a testosterone 1% medication product (50 mg/5 g) with a performance period through May 8, 2025. The contract is a firm fixed-price, non-set-aside arrangement, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,095.26, is for the delivery of Testosterone 1% (25mg/2.5g) medical supplies. The contract is a Firm Fixed Price Delivery Order with a completion date of March 20, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $1,264.96 firm fixed-price contract is for the supply of Testosterone 1% (25mg/2.5g) pharmaceutical product, with a period of performance through July 11, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle to provide a wide range...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of testosterone 1% (25mg/2.5g) in a 2.5g package. The contract has a firm fixed price of $1,185.92 and a completion date of June 25, 2025. This award is not set-aside and represents an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB24D2216
    Indefinite Delivery Contract
  • SPE2DB24D2216-SPE2DB24FGMDK
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,575.02, is for the delivery of testosterone 1% (25mg/2.5g) packaged units of 2.5g. This is a firm fixed-price contract with no set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/17/25, 9:57 AM